The marker appears on routine blood panels, yet the number can tell two very different stories about your health.
Approval based on phase III data showing unprecedented functional cure rates compared to standard of care ...
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that the company and its research collaborators will present 25 abstracts-including five rapid oral ...
AbbVie announced that new and updated data from its broad solid tumor portfolio will be presented at the 2026 European Society for Medical Oncology (ESMO) Congress, taking place October 23-27 in ...
Chronic Kidney Disease (CKD) is a progressive condition in which the kidneys gradually lose their ability to filter waste ...
A new review in Genes & Diseases outlines how co-targeting EGFR alongside other tumor-driving molecules, delivered via ...
For patients with EGFR PACC-mutated non-small cell lung cancer (NSCLC), the targeted therapy firmonertinib achieved durable ...
Thousands of people living with diabetes could be missing out on early detection of chronic kidney disease because of low uptake of a simple urine test, kidney health experts have warned. Despite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results